JPWO2020047103A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020047103A5
JPWO2020047103A5 JP2021511655A JP2021511655A JPWO2020047103A5 JP WO2020047103 A5 JPWO2020047103 A5 JP WO2020047103A5 JP 2021511655 A JP2021511655 A JP 2021511655A JP 2021511655 A JP2021511655 A JP 2021511655A JP WO2020047103 A5 JPWO2020047103 A5 JP WO2020047103A5
Authority
JP
Japan
Prior art keywords
composition
taurolidine
administered
nanoparticles
outer coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021511655A
Other languages
English (en)
Japanese (ja)
Other versions
JP7530351B2 (ja
JP2021535173A (ja
JP2021535173A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/048579 external-priority patent/WO2020047103A1/en
Publication of JP2021535173A publication Critical patent/JP2021535173A/ja
Publication of JPWO2020047103A5 publication Critical patent/JPWO2020047103A5/ja
Publication of JP2021535173A5 publication Critical patent/JP2021535173A5/ja
Application granted granted Critical
Publication of JP7530351B2 publication Critical patent/JP7530351B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021511655A 2018-08-28 2019-08-28 若年哺乳動物の身体における神経芽細胞腫を治療するための方法および組成物 Active JP7530351B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862723592P 2018-08-28 2018-08-28
US62/723,592 2018-08-28
PCT/US2019/048579 WO2020047103A1 (en) 2018-08-28 2019-08-28 Methods and compositions for treating neuroblastoma in a juvenile mammalian body

Publications (4)

Publication Number Publication Date
JP2021535173A JP2021535173A (ja) 2021-12-16
JPWO2020047103A5 true JPWO2020047103A5 (https=) 2022-09-02
JP2021535173A5 JP2021535173A5 (https=) 2022-09-02
JP7530351B2 JP7530351B2 (ja) 2024-08-07

Family

ID=69645361

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021511655A Active JP7530351B2 (ja) 2018-08-28 2019-08-28 若年哺乳動物の身体における神経芽細胞腫を治療するための方法および組成物

Country Status (7)

Country Link
EP (1) EP3843745A4 (https=)
JP (1) JP7530351B2 (https=)
KR (1) KR102904381B1 (https=)
CN (1) CN113164491A (https=)
AU (1) AU2019330831B2 (https=)
CA (1) CA3111015A1 (https=)
WO (1) WO2020047103A1 (https=)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479481B1 (en) 1999-06-04 2002-11-12 Ed. Geistlich Soehne Ag Fur Chemische Industrie Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
US7345039B2 (en) * 1999-06-04 2008-03-18 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
JP5027369B2 (ja) 1999-12-06 2012-09-19 ガイストリッヒ ファーマ アーゲー 腫瘍を治療する方法
ATE354380T1 (de) * 2003-02-03 2007-03-15 Polaschegg Hans-Dietrich Dr Te Zusammensetzung zur prävention von infektionen durch subkutane prothesen
US20080177217A1 (en) * 2004-05-14 2008-07-24 Hans-Dietrich Polaschegg Taurolidine Formulations and Delivery: Therapeutic Treatments and Antimicrobial Protection Against Bacterial Biofilm Formation
WO2013190355A1 (en) * 2012-06-18 2013-12-27 Geistlich Pharma Ag Oxathiazine derivatives as antibacterial and anticancer agents
EP3402527B1 (en) 2016-01-11 2022-09-28 CorMedix Inc. Therapeutic nanoparticles for the treatment of neuroblastoma and other cancers
CN106974901A (zh) * 2016-01-18 2017-07-25 贵州益佰制药股份有限公司 洛铂在制备治疗神经母细胞瘤药物中的应用
WO2018129061A1 (en) * 2017-01-05 2018-07-12 Cormedix Inc. Antimicrobial delivery system for the prevention and treatment of infections in the colon

Similar Documents

Publication Publication Date Title
ES2198196B2 (es) Composiciones topicas que comprenden un analgesico opioide y un antagonista de nmda.
CA2412795A1 (en) Improved liposomal camptothecins and uses thereof
CZ20014289A3 (cs) Nové pouľití sloučenin jako antibakteriálních činidel
BR112020008128A2 (pt) comprimidos de liberação retardada de deferiprona e métodos para utilização dos mesmos
Mohan et al. Pharmacological agents in dentistry: a review
JPH11504050A (ja) 生物学的応答修飾因子としての双性イオンの組成物及び方法
ES2211916T3 (es) Composicion para aliviar dolor, que contiene un analgesico no narcortico y un potenciador de analgesia.
JP2021535163A5 (https=)
AR046410A1 (es) Composiciones farmaceuticas para la liberacion modificada de modafinilo
JPWO2020047103A5 (https=)
JP2021535173A5 (https=)
FI4255563T3 (fi) 5’-o-fenyyliasetyyliuridiini ja terapeuttinen käyttö
CN101854927B (zh) 具有麻醉效果的抗菌化合物的应用
US20110250291A1 (en) Use of arsenic for cancer therapy protection
Dhanapal et al. Efficacy of single dose of transdermal patch as a pre-operative analgesic in root canal treatment-a randomized clinical trial
JPH0455172B2 (https=)
ES2306905T3 (es) Utilizacion del tenatoprazol para el tratamiento del reflujo gastroesofagico.
US12053478B2 (en) Taurultam, taurinamide and methylene glycol treatment for MYC—expressing tumors in mammalian bodies
JPH11505851A (ja) 放射線障害の処置のための薬剤
ES3017257T3 (en) Abt-751 and ionizing radiation for use in treating a brain tumor
JP2025128194A (ja) 哺乳動物の身体におけるmyc発現腫瘍のタウロリジン治療
JPWO2020047530A5 (https=)
RU2786675C2 (ru) Синергическое лечение рака
JP2021535167A5 (https=)
CN108883104A (zh) 用于在治疗成熟脑损伤中使用的mGluR5的负性变构调节剂